The SAPHO Syndrome

Seminars in Arthritis and Rheumatism

Volumn 42, Issue 3, 2012, Pages 254-265

  Nguyen, Minhchau Thi ^a   Borchers, Andrea ^a   Selmi, Carlo ^a,b   Naguwa, Stanley M ^a   Cheema, Gurtej ^a   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Acne; Hyperostosis; Osteitis; Pustulosis; Synovitis

Indexed keywords

ADALIMUMAB; ANALGESIC AGENT; ANTIINFECTIVE AGENT; AZATHIOPRINE; BISPHOSPHONIC ACID DERIVATIVE; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PAMIDRONIC ACID; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR INHIBITOR;

ARTICLE; BONE RADIOGRAPHY; BONE RESECTION; CHRONIC OSTEOMYELITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DECORTICATION; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; EARLY DIAGNOSIS; GENE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; IL1RN GENE; LPIN2 GENE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PSTPIP1 GENE; PSTPIP2 GENE; REPEATED DRUG DOSE; SAPHO SYNDROME; SINGLE DRUG DOSE; SYSTEMIC THERAPY; THORAX WALL; WHOLE BODY SCINTISCANNING;

ACQUIRED HYPEROSTOSIS SYNDROME; ADOLESCENT; ADULT; AGED; ANALGESICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CAUSALITY; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MANAGEMENT; SKIN; SKIN DISEASES; YOUNG ADULT;

EID: 84869108370     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2012.05.006     Document Type: Article

References (106)

1. Chamot A.M., Benhamou C.L., Kahn M.F., Beraneck L., Kaplan G., Prost A. Le syndrome acné pustulose hyperostose ostéite. Résultats d'une enquête nationale; 85 observations. [Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases.]. Rev Rhum Mal Osteoartic 1987, 54:187-196.
2. Earwaker J.W., Cotten A. SAPHO: Syndrome or concept?. Imaging findings. Skeletal Radiol 2003, 32:311-327.
3. Benhamou C.L., Chamot A.M., Kahn M.F. Synovitis-acne-pustulosis hyperostosis-osteomyelitis syndrome (SAPHO). A new syndrome among the spondyloarthropathies?. Clin Exp Rheumatol 1988, 6:109-112.
4. Giedion A., Holthusen W., Masel L.F., Vischer D. [Subacute and chronic "symmetrical" osteomyelitis] (article in multiple languages). Ann Radiol (Paris) 1972, 15:329-342.
5. Björkstén B., Boquist L. Histopathological aspects of chronic recurrent multifocal osteomyelitis. J Bone Joint Surg Br 1980, 62:376-380.
6. Schilling F. [Chronic recurrent multifocal osteomyelitis (CRMO)]. Rofo 1998, 168:115-127.
7. Vittecoq O., Said L.A., Michot C., Mejjad O., Thomine J.M., Mitrofanoff P., et al. Evolution of chronic recurrent multifocal osteitis toward spondylarthropathy over the long term. Arthritis Rheum 2000, 43:109-119.
8. Bognar M., Blake W., Agudelo C. Chronic recurrent multifocal osteomyelitis associated with Crohn's disease. Am J Med Sci 1998, 315:133-135.
9. Tlougan B.E., Podjasek J.O., O'Haver J., Cordova K.B., Nguyen X.H., Tee R., et al. Chronic recurrent multifocal osteomyelitis (CRMO) and synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with associated neutrophilic dermatoses: A report of seven cases and review of the literature. Pediatr Dermatol 2009, 26:497-505.
10. Huber A.M., Lam P.Y., Duffy C.M., Yeung R.S., Ditchfield M., Laxer D., et al. Chronic recurrent multifocal osteomyelitis: Clinical outcomes after more than five years of follow-up. J Pediatr 2002, 141:198-203.
11. Jansson A., Renner E.D., Ramser J., Mayer A., Haban M., Meindl A., et al. Classification of non-bacterial osteitis: Retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatology (Oxford) 2007, 46:154-160.
12. Schilling F., Märker-Hermann E. Die chronisch rekurrierende multifokale osteomyelitis in Assoziation mit chronisch entzündlichen Darmerkrankungen: Die enteropathische CRMO. [Chronic recurrent multifocal osteomyelitis in association with chronic inflammatory bowel disease: entheropathic CRMO.]. Z Rheumatol 2003, 62:527-538.
13. Kahn M.F., Khan M.A. The SAPHO syndrome. Baillieres Clin Rheumatol 1994, 8:333-362.
14. Khanna G., Sato T.S., Ferguson P. Imaging of chronic recurrent multifocal osteomyelitis. RadioGraphics 2009, 29:1159-1177.
15. Schilling F. SAPHO Syndrom accessed March 1, 2012. http://www.orphanetnet.
16. Hayem G., Bouchaud-Chabot A., Benali K., Roux S., Palazzo E., Silbermann-Hoffman O., et al. SAPHO syndrome: A long-term follow-up study of 120 cases. Semin Arthritis Rheum 1999, 29:159-171.
17. Colina M., Govoni M., Orzincolo C., Trotta F. Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: A single center study of a cohort of 71 subjects. Arthritis Rheum 2009, 61:813-821.
18. Grosjean C., Hurtado-Nedelec M., Nicaise-Roland P., Ferreyra-Dillon R., Bollet C., Quintin E., et al. Prevalence of autoantibodies in SAPHO syndrome: A single-center study of 90 patients. J Rheumatol 2010, 37:639-643.
19. Hurtado-Nedelec M., Chollet-Martin S., Chapeton D., Hugot J.P., Hayem G., Gérard B. Genetic susceptibility factors in a cohort of 38 patients with SAPHO syndrome: A study of PSTPIP2, NOD2, and LPIN2 genes. J Rheumatol 2010, 37:401-409.
20. Suei Y., Taguchi A., Tanimoto K. Diagnostic points and possible origin of osteomyelitis in synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome: A radiographic study of 77 mandibular osteomyelitis cases. Rheumatology (Oxford) 2003, 42:1398-1403.
21. Sonozaki H., Mitsui H., Miyanaga Y., Okitsu K., Igarashi M., Hayashi Y., et al. Clinical features of 53 cases with pustulotic arthro-osteitis. Ann Rheum Dis 1981, 40:547-553.
22. Sallés M., Olivé A., Perez-Andres R., Holgado S., Mateo L., Riera E., et al. The SAPHO syndrome: A clinical and imaging study. Clin Rheumatol 2011, 30:245-249.
23. Beretta-Piccoli B.C., Sauvain M.J., Gal I., Schibler A., Saurenmann T., Kressebuch H., et al. Synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome in childhood: A report of ten cases and review of the literature. Eur J Pediatr 2000, 159:594-601.
24. Jurik A.G., Helmig O., Ternowitz T., Møller B.N. Chronic recurrent multifocal osteomyelitis: A follow-up study. J Pediatr Orthop 1988, 8:49-58.
25. Björkstén B., Gustavson K.H., Eriksson B., Lindholm A., Nordström S. Chronic recurrent multifocal osteomyelitis and pustulosis palmoplantaris. J Pediatr 1978, 93:227-231.
26. Sofman M.S., Prose N.S. Dermatoses associated with sterile lytic bone lesions. J Am Acad Dermatol 1990, 23:494-498.
27. Depasquale R., Kumar N., Lalam R.K., Tins B.J., Tyrrell P.N., Singh J., et al. SAPHO: What radiologists should know. Clin Radiol 2012, 67:195-206.
28. Catalano-Pons C., Comte A., Wipff J., Quartier P., Faye A., Gendrel D., et al. Clinical outcome in children with chronic recurrent multifocal osteomyelitis. Rheumatology (Oxford) 2008, 47:1397-1399.
29. Kahn M.F., Bouvier M., Palazzo E., Tebib J.G., Colson F. Sternoclavicular pustulotic osteitis (SAPHO). 20-Year interval between skin and bone lesions. J Rheumatol 1991, 18:1104-1108.
30. Rosner I.A., Burg C.G., Wisnieski J.J., Schacter B.Z., Richter D.E. The clinical spectrum of the arthropathy associated with hidradenitis suppurativa and acne conglobata. J Rheumatol 1993, 20:684-687.
31. Bhalla R., Sequeira W. Arthritis associated with hidradenitis suppurativa. Ann Rheum Dis 1994, 53:64-66.
32. Steinhoff J.P., Cilursu A., Falasca G.F., Guzman L., Reginato A.J. A study of musculoskeletal manifestations in 12 patients with SAPHO syndrome. J Clin Rheumatol 2002, 8:13-22.
33. Kahn M.F., Chamot A.M. SAPHO syndrome. Rheum Dis Clin North Am 1992, 18:225-246.
34. Yamasaki O., Iwatsuki K., Kaneko F. A case of SAPHO syndrome with pyoderma gangrenosum and inflammatory bowel disease masquerading as Behçet's disease. Adv Exp Med Biol 2003, 528:339-341.
35. Conway R., Ryan A., Khan K. A case of SAPHO syndrome presenting as isolated iliitis and spondylitis. J Rheumatol 2011, 38:1810-1811.
36. Sonozaki H., Azuma A., Okai K., Nakamura K., Fukuoka S., Tateishi A., et al. Clinical features of 22 cases with "inter-sterno-costo-clavicular ossification." A new rheumatic syndrome. Arch Orthop Traumat Surg 1979, 95:13-22.
37. Colhoun E.N., Hayward C., Evans K.T. Inter-sterno-costo-clavicular ossification. Clin Radiol 1987, 38:33-38.
38. Laredo J.D., Vuillemin-Bodaghi V., Boutry N., Cotten A., Parlier-Cuau C. SAPHO syndrome: MR appearance of vertebral involvement. Radiology 2007, 242:825-831.
39. Zemann W., Pau M., Feichtinger M., Ferra-Matschy B., Kaercher H. SAPHO syndrome with affection of the mandible: Diagnosis, treatment, and review of literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011, 111:190-195.
40. Freyschmidt J., Sternberg A. The bullhead sign: Scintigraphic pattern of sternocostoclavicular hyperostosis and pustulotic arthroosteitis. Eur Radiol 1998, 8:807-812.
41. Davies A.M., Marino A.J., Evans N., Grimer R.J., Deshmukh N., Mangham D.C. SAPHO syndrome: 20-year follow-up. Skeletal Radiol 1999, 28:159-162.
42. Reith J.D., Bauer T.W., Schils J.P. Osseous manifestations of SAPHO (synovitis, acne, pustulosis, hyperostosis, osteitis) syndrome. Am J Surg Pathol 1996, 20:1368-1377.
43. Van Doornum S., Barraclough D., McColl G., Wicks I. SAPHO: Rare or just not recognized?. Semin Arthritis Rheum 2000, 30:70-77.
44. Yu L., Kasser J.R., O'Rourke E., Kozakewich H. Chronic recurrent multifocal osteomyelitis. Association with vertebra plana. J Bone Joint Surg Am 1989, 71:105-112.
45. Girschick H.J., Huppertz H.I., Harmsen D., Krauspe R., Müller-Hermelink H.K., Papadopoulos T. Chronic recurrent multifocal osteomyelitis in children: Diagnostic value of histopathology and microbial testing. Hum Pathol 1999, 30:59-65.
46. Boutin R.D., Resnick D. The SAPHO syndrome: An evolving concept for unifying several idiopathic disorders of bone and skin. AJR Am J Roentgenol 1998, 170:585-591.
47. Job-Deslandre C., Krebs S., Kahan A. Chronic recurrent multifocal osteomyelitis: Five-year outcomes in 14 pediatric cases. Joint Bone Spine 2001, 68:245-251.
48. Edlund E., Johnsson U., Lidgren L., Pettersson H., Sturfelt G., Svensson B., et al. Palmoplantar pustulosis and sternocostoclavicular arthro-osteitis. Ann Rheum Dis 1988, 47:809-815.
49. Assmann G., Kueck O., Kirchhoff T., Rosenthal H., Voswinkel J., Pfreundschuh M., et al. Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation: An interventional study. Arthritis Res Ther 2009, 11:R140.
50. Eyrich G.K., Harder C., Sailer H.F., Langenegger T., Bruder E., Michel B.A. Primary chronic osteomyelitis associated with synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO syndrome). J Oral Pathol Med 1999, 28:456-464.
51. Guignard S., Job-Deslandre C., Sayag-Boukris V., Kahan A. Pamidronate treatment in SAPHO syndrome. Joint Bone Spine 2002, 69:392-396.
52. Wagner A.D., Andresen J., Jendro M.C., Hülsemann J.L., Zeidler H. Sustained response to tumor necrosis factor alpha-blocking agents in two patients with SAPHO syndrome. Arthritis Rheum 2002, 46:1965-1968.
53. Wolber C., David-Jelinek K., Udvardi A., Artacker G., Volc-Platzer B., Kurz H. Sacroileitis im rahmen eines SAPHO Syndroms-Promptes ansprechen auf etanercept [Successful therapy of sacroiliitis in SAPHO syndrome by etanercept]. Wien Med Wochenschr 2011, 161:204-208.
54. Ben Abdelghani K., Dran D.G., Gottenberg J.E., Morel J., Sibilia J., Combe B. Tumor necrosis factor-alpha blockers in SAPHO syndrome. J Rheumatol 2010, 37:1699-1704.
55. De Souza A., Solomon G.E., Strober B.E. SAPHO syndrome associated with hidradenitis suppurativa successfully treated with infliximab and methotrexate. Bull NYU Hosp Jt Dis 2011, 69:185-187.
56. Castellví I., Bonet M., Narváez J.A., Molina-Hinojosa J.C. Successful treatment of SAPHO syndrome with adalimumab: A case report. Clin Rheumatol 2010, 29:1205-1207.
57. Vilar-Alejo J., Dehesa L., de la Rosa-del Rey P., Novoa-Medina J., Valerón Almazán P., Santana Medina N., et al. SAPHO syndrome with unusual cutaneous manifestations treated successfully with etanercept. Acta Derm Venereol 2010, 90:531-532.
58. Arias-Santiago S., Sanchez-Cano D., Callejas-Rubio J.L., Fernández-Pugnaire M.A., Ortego-Centeno N. Adalimumab treatment for SAPHO syndrome. Acta Derm Venereol 2010, 90:301-302.
59. Fruehauf J., Cierny-Modre B., Caelen Lel S., Schwarz T., Weinke R., Aberer E. Response to infliximab in SAPHO syndrome. BMJ Case Rep 2009, 2009.
60. Marangoni R.G., Halpern A.S. Chronic recurrent multifocal osteomyelitis primarily affecting the spine treated with anti-TNF therapy. Spine (Phila Pa 1976) 2010, 35:E253-E256.
61. Eleftheriou D., Gerschman T., Sebire N., Woo P., Pilkington C.A., Brogan P.A. Biologic therapy in refractory chronic non-bacterial osteomyelitis of childhood. Rheumatology (Oxford) 2010, 49:1505-1512.
62. Amital H., Applbaum Y.H., Aamar S., Daniel N., Rubinow A. SAPHO syndrome treated with pamidronate: An open-label study of 10 patients. Rheumatology (Oxford) 2004, 43:658-661.
63. Massara A., Cavazzini P.L., Trotta F. In SAPHO syndrome anti-TNF-alpha therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations. Rheumatology (Oxford) 2006, 45:730-733.
64. Van Den Eynde M., Lecluyse K., Chioccioli C., Brouckaert M., Caussin E., Lammens P. Maladie de Crohn et syndrome SAPHO, au cours d'un traitement à l'infliximab: Cas clinique et revue de la littérature [Crohn's disease and the SAPHO syndrome during treatment with infliximab: a case report and review of literature]. Gastroenterol Clin Biol 2007, 31:607-610.
65. Borchers A.T., Leibushor N., Cheema G.S., Naguwa S.M., Gershwin M.E. Immune-mediated adverse effects of biologicals used in the treatment of rheumatic diseases. J Autoimmun 2011, 37:273-288.
66. Colina M., La Corte R., Trotta F. Sustained remission of SAPHO syndrome with pamidronate: A follow-up of fourteen cases and a review of the literature. Clin Exp Rheumatol 2009, 27:112-115.
67. Solau-Gervais E., Soubrier M., Gerot I., Grange L., Puechal X., Sordet C., et al. The usefulness of bone remodelling markers in predicting the efficacy of pamidronate treatment in SAPHO syndrome. Rheumatology (Oxford) 2006, 45:339-342.
68. Valls-Roc M., Sanmarti M., Salles M., Holgado S., Olive A. SAPHO syndrome and pamidronate revisited. Rheumatology (Oxford) 2005, 44:137. Author reply 137-8.
69. Kerrison C., Davidson J.E., Cleary A.G., Beresford M.W. Pamidronate in the treatment of childhood SAPHO syndrome. Rheumatology (Oxford) 2004, 43:1246-1251.
70. Miettunen P.M., Wei X., Kaura D., Reslan W.A., Aguirre A.N., Kellner J.D. Dramatic pain relief and resolution of bone inflammation following pamidronate in 9 pediatric patients with persistent chronic recurrent multifocal osteomyelitis (CRMO). Pediatr Rheumatol Online J 2009, 7:2.
71. Kopterides P., Pikazis D., Koufos C. Successful treatment of SAPHO syndrome with zoledronic acid. Arthritis Rheum 2004, 50:2970-2973.
72. Just A., Adams S., Brinkmeier T., Barsegian V., Lorenzen J., Schilling F., et al. Successful treatment of primary chronic osteomyelitis in SAPHO syndrome with bisphosphonates. J Dtsch Dermatol Ges 2008, 6:657-660.
73. Soyfoo M.S., Gangji V., Margaux J. Successful treatment of SAPHO syndrome with ibandronate. J Clin Rheumatol 2010, 16:253.
74. Fioravanti A., Cantarini L., Burroni L., Mazzei M.A., Volterrani L., Galeazzi M. Efficacy of alendronate in the treatment of the SAPHO syndrome. J Clin Rheumatol 2008, 14:183-184.
75. Ichikawa J., Sato E., Haro H., Ando T., Maekawa S., Hamada Y. Successful treatment of SAPHO syndrome with an oral bisphosphonate. Rheumatol Int 2009, 29:713-715.
76. Galadari H., Bishop A.G., Venna S.S., Sultan E., Do D., Zeltser R. Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome treated with a combination of isotretinoin and pamidronate. J Am Acad Dermatol 2009, 61:123-125.
77. van Holsbeeck M., Martel W., Dequeker J., Favril A., Gielen J., Verschakelen J., et al. Soft tissue involvement, mediastinal pseudotumor, and venous thrombosis in pustulotic arthro-osteitis. A study of eight new cases. Skeletal Radiol 1989, 18:1-8.
78. Yanamoto S., Kawasaki G., Yoshitomi I., Mizuno A. Diffuse chronic sclerosing osteomyelitis of the mandible with synovitis, acne, pustulosis, hyperostosis, and osteitis: Report of a long-term follow-up case. J Oral Maxillofac Surg 2010, 68:212-217.
79. Maugars Y., Berthelot J.M., Ducloux J.M., Prost A. SAPHO syndrome: A followup study of 19 cases with special emphasis on enthesis involvement. J Rheumatol 1995, 22:2135-2141.
80. Wipff J., Adamsbaum C., Kahan A., Job-Deslandre C. Chronic recurrent multifocal osteomyelitis. Joint Bone Spine 2011, 78:555-560.
81. Govoni M., Colina M., Massara A., Trotta F. SAPHO syndrome and infections. Autoimmun Rev 2009, 8:256-259.
82. Hurtado-Nedelec M., Chollet-Martin S., Nicaise-Roland P., Grootenboer-Mignot S., Ruimy R., Meyer O., et al. Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome. Rheumatology (Oxford) 2008, 47:1160-1167.
83. Golla A., Jansson A., Ramser J., Hellebrand H., Zahn R., Meitinger T., et al. Chronic recurrent multifocal osteomyelitis (CRMO): Evidence for a susceptibility gene located on chromosome 18q21.3-18q22. Eur J Hum Genet 2002, 10:217-221.
84. Gonzalez T., Gantes M., Bustabad S., Diaz-Flores L. Acne fulminans associated with arthritis in monozygotic twins. J Rheumatol 1985, 12:389-391.
85. Darley C.R., Currey H.L., Baker H. Acne fulminans with arthritis in identical twins treated with isotretinoin. J R Soc Med 1984, 77:328-330.
86. Festen J.J., Kuipers F.C., Schaars A.H. Multifocal recurrent periostitis responsive to colchicine. Scand J Rheumatol 1985, 14:8-14.
87. Kurc D., De Saint-Père R., Madoule P., Laoussadi S., Caquet R. [Chronic osteitis and arthritis of palmoplantar pustulosis. A familial form of B-27 negative spondylarthropathy]. Rev Med Interne 1987, 8:79-84.
88. Dumolard A., Gaudin P., Juvin R., Bost M., Peoc'h M., Phelip X. SAPHO syndrome or psoriatic arthritis?. A familial case study. Rheumatol Oxf Engl 1999, 38:463-467.
89. Ben Becher S., Essaddam H., Nahali N., Ben Hamadi F., Mouelhi M.H., Hammou A., et al. Recurrent multifocal periostosis in children. Report of a familial form]. Ann Paediatr (Paris) 1991, 38:345-349.
90. Riffat G., Alexandre C., Pallot-Prades B., Prallet B., Cartry O., Chappard D. A propos d'une observation familiale de SAHPO. Rhumatologie 1991, 43:159-163.
91. Eyrich G.K., Langenegger T., Bruder E., Sailer H.F., Michel B.A. Diffuse chronic sclerosing osteomyelitis and the synovitis, acne, pustolosis, hyperostosis, osteitis (SAPHO) syndrome in two sisters. Int J Oral Maxillofac Surg 2000, 29:49-53.
92. Ferguson P.J., Lokuta M.A., El-Shanti H.I., Muhle L., Bing X., Huttenlocher A. Neutrophil dysfunction in a family with a SAPHO syndrome-like phenotype. Arthritis Rheum 2008, 58:3264-3269.
93. Ferguson P.J., El-Shanti H.I. Autoinflammatory bone disorders. Curr Opin Rheumatol 2007, 19:492-498.
94. Schilling F., Kessler S., Das S.-S. Klinisch-rheumatologische und radiologische Differenzierung und Klassifizierung eines Krankengutes von 86 fällen [SAPHO syndrome: clinico-rheumatologic and radiologic differentiation and classification of a patient sample of 86 cases]. Z Rheumatol 2000, 59:1-28.
95. Olivieri I., Padula A., Ciancio G., Salvarani C., Niccoli L., Cantini F. Successful treatment of SAPHO syndrome with infliximab: Report of two cases. Ann Rheum Dis 2002, 61:375-376.
96. Queiro R., Moreno P., Sarasqueta C., Alperi M., Riestra J.L., Ballina J. Synovitis-acne-pustulosis-hyperostosis-osteitis syndrome and psoriatic arthritis exhibit a different immunogenetic profile. Clin Exp Rheumatol 2008, 26:125-128.
97. Ferguson P.J., Chen S., Tayeh M.K., Ochoa L., Leal S.M., Pelet A., et al. Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J Med Genet 2005, 42:551-557.
98. Aksentijevich I., Masters S.L., Ferguson P.J., Dancey P., Frenkel J., van Royen-Kerkhoff A., et al. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med 2009, 360:2426-2437.
99. Wendling D., Prati C., Aubin F. Anakinra treatment of SAPHO syndrome: Short-term results of an open study. Ann Rheum Dis 2012, 71(6):1098-1100.
100. Assmann G., Wagner A.D., Monika M., Pfoehler C., Pfreundschuh M., Tilgen W., et al. Single-nucleotide polymorphisms p53 G72C and Mdm2 T309G in patients with psoriasis, psoriatic arthritis, and SAPHO syndrome. Rheumatol Int 2010, 30:1273-1276.
101. Chatzikyriakidou A., Voulgari P.V., Drosos A.A. What is the role of HLA-B27 in spondyloarthropathies?. Autoimmun Rev 2011, 10:464-468.
102. Ehrenfeld M. Geoepidemiology: The environment and spondyloarthropathies. Autoimmun Rev 2010, 9:A325-A329.
103. Mansour M., Cheema G.S., Naguwa S.M., Greenspan A., Borchers A.T., Keen C.L., et al. Ankylosing spondylitis: A contemporary perspective on diagnosis and treatment. Semin Arthritis Rheum 2007, 36:210-223.
104. Youinou P., Pers J.O., Gershwin M.E., Shoenfeld Y. Geo-epidemiology and autoimmunity. J Autoimmun 2010, 34:J163-J167.
105. McGonagle D., McDermott M.F. A proposed classification of the immunological diseases. PLoS Med 2006, 3:e297.
106. Cotten A., Flipo R.M., Mentre A., Delaporte E., Duquesnoy B., Chastanet P. SAPHO syndrome. RadioGraphics 1995, 15:1147-1154.